A Leading Pharmaceutical Brand Increased Adherence 29% YoY with Swoop’s Patented Predictive Non-Adherence Audiences
With an increased incidence in substance use disorders (SUDs), a MAT therapy wanted to increase adherence within its patient population to drive positive patient outcomes. Leveraging Swoop’s patented predictive technology, the brand was able to accurately identify patients most likely to become non-adherent and activate them programmatically across premium inventory.
Advertising on CTV Increases HCP Appointments for Mental Health Drug by 20%
A pharmaceutical brand needed to connect with a limited patient population diagnosed with a sensitive conditionand their caregivers. Swoop utilized its privacy-safe real world health data to create a targetable niche segment for activation on CTV platforms.
Help patients start and stay on therapy programs prescribed by their doctors
SwoopRx by Nimble connects prescription fulfillment capabilities with commercial intelligence to turn real-world signals into action, improve medication adherence, and reduce treatment delays.
Adding Nimble advances Swoop’s position as the only integrated ecosystem built to connect patients and HCPs with the right information to improve health outcomes.
Swoop earned the title of Best AI-Powered Health Solution for its Predictive Adherence Audiences and Best Health Equity or Accessibility Innovation for its en español patient Communities.
“Patient and healthcare provider experience of diroximel fumarate: considerations for selecting disease-modifying therapy,” offers real-world insights into the treatment experience for MS patients.